Baird Medical Investment  Limited logo

Baird Medical Investment Limited

BDMD | NASDAQ
Chart Builder DCF Calculator
$0.79
-$0.05 (-6.05%)
Sep 22, 2026, 2:13 PM ET · Market open

Market Data

Market Cap
$35.49M
Enterprise Value
$49.43M
Beta
-1.14
Average Volume
112.02K
Shares Outstanding (Diluted)
40.98M
Shares Change YoY
448.49%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
KYG0705H1039

Price Performance

Price Change 1M
-26.3%
Price Change 3M
-17.6%
Price Change 6M
-62.0%
Price Change YTD
-37.3%
Price Change 1Y
-66.5%
Price Change 3Y
-92.1%
Price Change 5Y
-91.4%
1M CAGR (ann.)
-31.1%
1Y CAGR (ann.)
-67.3%
5Y CAGR (ann.)
N/A
All-Time CAGR
-40.1%

Valuation

PE Ratio
-1.53
Forward PE
9.12
PEG Ratio
0.00
Forward PEG
-0.02
PS Ratio
1.45
Forward PS
1.10
PB Ratio
1.02
P/FCF Ratio
-25.60
P/Adj. FCF Ratio
-25.60
P/OCF Ratio
16.80
EV/Sales
2.02
EV/EBIT
-3.45
EV/EBITDA
-3.61
EV/FCF
-35.65
Earnings Yield
-65.5%
FCF Yield
-3.9%
Adj. FCF Yield
-3.9%

Financial Health

Net Debt
$13.93M
Total Debt
$14.22M
Cash & Short-Term Investments
$289.08K
Total Assets
$73.85M
Current Ratio
1.29
Quick Ratio
1.26
Debt / Equity Ratio
0.41
Debt / EBITDA
-1.04
Debt / FCF
-10.26
OCF / Debt
-0.09
Interest Coverage
-20.07
Altman Z-Score
0.39
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
85.6%
Operating Profit Margin
-58.5%
EBITDA Margin
-53.2%
Net Profit Margin
-65.2%
FCF Margin
-5.7%
Adj. FCF Margin
-5.7%
SBC / Revenue
9.7%
SBC Impact (per share)
N/A

Returns

Return on Assets
-21.6%
Return on Equity
-48.3%
Return on Invested Capital
-27.0%
Return on Capital Employed
-36.8%
Return on Tangible Assets
-21.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-13.7%
Revenue CAGR 5Y
4.5%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-2606.3%
EPS CAGR 5Y
-159.9%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
24.0%
FCF CAGR 5Y
-44.9%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Sep 2, 2026
EPS Estimate (next Q)
$0.04
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$12M
Revenue Growth Est (next Q)
50.8%

Cash Flow

Operating Cash Flow
$-1.34M
Free Cash Flow
$-1.39M
Adj. Free Cash Flow
$-1.39M
FCF Per Share
$0.05
OCF Per Share
$0.05
OCF/S Ratio
7.6%

Income Statement

Revenue
$24.49M
Gross Profit
$20.97M
Operating Income
$-14.33M
EBITDA
$-13.71M
Net Income
$-15.97M
EPS (Diluted)
-$0.55
Revenue / Employee
$167.76K
Profit / Employee
$-109.39K
Employees
146

© 2026 bestshares.com. All rights reserved.